Urology Flashcards

(56 cards)

1
Q

Urological cancers

A
Prostate
Kidney
Bladder
Testis 
Penile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for prostate cancer

A

Age
FHx
BRCA2
Ethnicity - black African

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Presentation of prostate cancer

A

Asymptomatic - high PSA

LUTS

Suspicious DRE

Bone pain - bone mets

Rare - ejaculatory problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LUTS

A

Hesitancy
Weak stream
Frequency
Feeling of incomplete urination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations for prostate cancer

A

DRE

PSA - before DRE

MRI prostate/pelvis before biopsy

  • helps decide biopsy technique
  • may not need biopsy

Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Methods of prostate biopsy

A

TRUS - transrectal ultrasound guided biopsy

Transperineal biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TRUS

A

Targets posterior area of the prostate

Local anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Transperineal biopsy

A

Targets whole area of prostate

General anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common causes of raised PSA

A
Prostate cancer 
Urinary infection 
Prostatitis 
Enlarged prostate - BPH 
Acute urinary retention 
DRE 
Intercourse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Problem with PSA

A

Poor sensitivity - false positives

May have prostate cancer but clinically insignificant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors influencing prostate cancer treatment

A
Age 
DRE
Stage 
PSA - no robotic prostatectomies when > 20 
Biopsy result - Gleason grade 
MRI scan and bone scan - mets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gleason score and intervention

A

Intervention when 3 + 4 or > 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Castrate resistant prostate cancer

A

Metastatic prostate cancer

Androgen independent prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metastatic prostate cancer

A

Bone metastasise - osteoblastic therefore sclerotic

Likely if PSA >20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of prostate cancer

A

Hormones (medical castration) - LHRH agonists

Surgical castration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LHRH agonists

A

LH normally has a pulsatile release

Initial LH flare - more symptomatic therefore give anti-androgen for first 28 days to prevent the flare

Then decreases as downregulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Palliative options for prostate cancer

A

Single dose radiotherapy

Bisphosphonates - zoledronic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Caution with LHRH antagonists

A

Can cause anaphylaxis as similar structure to histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of metastatic castration resistant prostate cancer

A

Add antiandrogen - bicalutamide

Consider prednisolone + docetaxel chemo if good performance status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Locally advanced prostate cancer treatment (no mets)

A

Radical radiotherapy with adjuvant hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Treatment of localised prostate cancer

A

Active surveillance
Radical prostatectomy - robotic
Radiotherapy - external beam or brachytherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Palliative treatment for localised prostate cancer

A

Deferred hormones - watchful waiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prostate screening

A

Opportunistic screening if patients are counselled

24
Q

Problems with prostate cancer screening

A
Lead time bias 
Length time bias
Overdiagnosis 
Over treatment  - side effects 
Not cost effective
25
Lead time bias
Identifying the disease earlier does not affect the prognosis however it seems that there are more years of survival
26
Length time bias
Overestimation of survival duration because prostate cancer can be asymptomatic and slowly progressing with a better prognosis. More aggressive diseases are asymptomatic for a shorter period and are detected after giving symptoms
27
Haematuria types
Visible | Non visible - seen on dipstick
28
When to refer haematuria
40+ with unexplained visible haematuria | 65+ with unexplained non visible haematuria
29
Differentials for haematuria
Cancer: - RCC - TCC - Bladder carcinoma - Advanced prostate cancer Other: - renal stones - UTI - glomerulonephritis - pyelonephritis/ cystitis - BPH
30
Investigations for haematuria in secondary care
Radiology - USS Urine - cytology Flexible cystoscopy
31
Investigations for haematuria in primary care
Bloods - U+Es, albumin/creatinine ratio | MSU - dipstick
32
Presentation of testicular cancer
Lump in body of testis | Painless
33
When to refer for 2 ww for testicular cancer
Testicular lump
34
What happens in a 2 ww referral
Urgent USS of scrotum | Testis tumour markers
35
Testis tumour markers
AFP Beta - hCG LDH
36
Risk factors for penile cancer
Risk factors for STIs | FHx
37
When to suspect penile cancer
Excluded STI Lump/ulcer/lesion is persistent despite treatment Recurrent balanitis and phimosis
38
Risk factors for bladder cancer
Persistent irritation - indwelling catheter, recurrent bladder stones Schistosomiasis Overflow incontinence Occupational exposure - rubber or plastic manufacture - arylamines - carbon/crude oil - polyaromatic hydrocarbons - painters, mechanics, hairdressers Smoking Male White
39
Types of bladder cancer
TCC | Squamous cell carcinoma - schistosomiasis
40
Treatment of bladder cancer
TURBT - transurethral resection of bladder cancer Single intravesical instillation of mitomycin
41
Treatment of intermediate/high risk non muscle invasive TCC
Check cystoscopy | Intravesical chemotherapy/ immunotherapy
42
Treatment of muscle invasive TCC
Potentially curative - neoadjuvant chemotherapy + radical cystectomy or radiotherapy Palliative chemotherapy or immunotherapy
43
Treatment of metastatic TCC
Palliative chemotherapy (cisplatin) or immunotherapy
44
Types of radical cystectomy
Ileal conduit Reconstruction - orthotopic Women - also remove fallopian tubes
45
Standard treatment of upper urinary tract TCC
Nephro - ureterectomy
46
Risk factors for RCC
White Male Smoking Obesity Dialysis
47
Treatment for localised RCC
Active surveillance Excision - radical or partial nephrectomy
48
Radical nephrectomy
Removal of kidney, adrenals, peri-nephritic and upper ureter
49
Metastatic RCC treatment
Palliative biological targeted therapies - targeting angiogenesis
50
Types of testicular cancer
Germ cell tumours - seminoma or teratoma | - usually in men < 45 yo
51
Risk factors of testicular cancer
Undescended testis
52
Treatment of testicular cancer
Inguinal orchidectomy
53
Which lymph nodes does scrotal cancer spread to
Inguinal lymph nodes
54
Which lymph nodes does testicular cancer spread to
Para - aortic
55
What type of cancer is penile cancer
Squamous cell carcinoma
56
Risk factors for penile cancer
Phimosis | HPV 16 and 18